Target intelligence / Profile preview

Src-like adaptor protein (SLAP)

Target
SLAP
Molecular classification
Adaptor protein, Signal transduction scaffold, Modular signaling adaptor
01

Overview

Src-like adaptor protein (SLAP) is a cytoplasmic signaling adaptor that contains SH2 and SH3 domains similar to the Src family kinases but lacks tyrosine kinase activity due to its unique C-terminal region. SLAP plays a crucial role as a negative regulator of multiple cell surface receptor signaling pathways, including T cell and B cell receptors, cytokine receptors, and receptor tyrosine kinases such as EPHA2, FLT3, c-KIT, PDGFR, EPOR, and CSF1R. By recruiting ubiquitin ligases (notably CBL), SLAP promotes ubiquitination and degradation of associated receptors or kinases, thereby attenuating signaling. SLAP’s primary biological functions include regulation of immune cell development, prevention of excessive cell proliferation and activation, and maintenance of immune tolerance. SLAP is expressed in many tissues, with a prominent role in lymphocytes but also influences diverse processes including osteoporosis and cancer. SLAP loss or downregulation is observed in some cancers, where it can function as a tumor suppressor. There are two homologous proteins in humans—SLAP (SLA) and SLAP-2 (SLA2). The provided name "Src like adaptor" is ambiguous, but most often, literature refers to SLAP/SLA as “Src-like adaptor protein.”

Other names
Src-like adaptor proteinSLAPSrc-like adapterSLAP-1SLA
02

Mechanism of action

null

03

Biological functions

Negative regulation of antigen receptor signalingSignal transductionUbiquitin-mediated protein degradationImmune cell development and regulationRegulation of receptor tyrosine kinase signalingModulation of cytokine signalingRegulation of SYK kinase signaling
04

Disease associations

CancerAutoimmune diseaseImmunodeficiencyType I hypersensitivityOsteoporosisNeurological disorders

Beyond the preview

Go deeper on Src-like adaptor protein (SLAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Src-like adaptor protein (SLAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call